Syncom Formulation (India) (BOM:524470) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524470 Syncom Formulation (India) Ltd BOM:524470
85 GF Score
Price ₹15.23
GF Value ₹20.29
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Syncom Formulation (India) FFO?

FFO (Funds from operations) only applies to REITs.

BOM:524470
85GF Score
Syncom Formulation (India) Ltd BOM:524470
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Syncom Formulation (India) (BOM:524470) Overvalued in 2026?

Based on GuruFocus' analysis, Syncom Formulation (India) stock appears to be undervalued. The current stock price of ₹15.23 is trading 24.9% below its estimated GF Value™ of ₹20.29. GuruFocus considers Syncom Formulation (India) to be Modestly Undervalued.

Key valuation signals for BOM:524470:

  • FFO:
  • GF Value™: ₹20.29 vs. price of ₹15.23 (24.9% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the BOM:524470 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Syncom Formulation (India) Business Description

Other Exchanges SYNCOMF:India
Address 207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018
Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.
85GF Score

Get the complete analysis for BOM:524470

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.23
Price
₹20.29
GF Value